AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2012
Sep 10, 2012
35124_dirs_2012-09-10_16f2af89-e6f7-47af-b486-c0592000c972.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-09-10
Reporting Person: Hooper Robert W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-10 | Celsion Corporation Common Stock | P | 1060 | $4.92 | Acquired | 69487 | Direct |
| 2012-09-10 | Celsion Corporation Common Stock | P | 100 | $4.94 | Acquired | 69587 | Direct |
| 2012-09-10 | Celsion Corporation Common Stock | P | 3800 | $4.96 | Acquired | 73387 | Direct |
| 2012-09-10 | Celsion Corporation Common Stock | P | 1549 | $4.97 | Acquired | 74936 | Direct |
| 2012-09-10 | Celsion Corporation Common Stock | P | 3491 | $4.95 | Acquired | 78427 | Direct |
Footnotes
F1: The Director purchased the shares on the open market.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23